Radiation medicine · 2005
Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
Сравнительное исследованиеОценочное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tozaki Mitsuhiro, Naruo Kouichirou, Fukuda Kunihiko
Аннотация
PURPOSE: To evaluate the effect of aortic and hepatic enhancement in patients with chronic liver disease who underwent dynamic MDCT using a higher concentration of contrast material within the same total iodine dose (80 mL of 370 mgI/mL), compared with a standard iodine concentration (100 mL of 300 mgI/mL).
MATERIALS AND METHODS: Dynamic MDCT of the liver was performed in 35 patients using different prefilled syringes (300 mgI/mL = group A, 370 mgI/mL = group B) during follow-up periods. The bolus-tracking program was used to automatically start the arterial phase scan. The attenuation values for the abdominal aorta, the hepatic parenchyma, and portal veins were measured.
RESULTS: Attenuation values of the aorta and hepatic artery in group B were significantly higher than those in group A (p<0.001). Attenuation values of the splenic vein (SV) in group A were higher than those in group B (p=0.045). The relative hepatic enhancement (RHE) values during the portal phase in group B were significantly higher than those in group A (p=0.014).
CONCLUSION: Administration of a higher iodine concentration in the contrast materials is advantageous for the detection of both hyper- and hypo-vascular hepatocellular carcinomas (HCCs).
MATERIALS AND METHODS: Dynamic MDCT of the liver was performed in 35 patients using different prefilled syringes (300 mgI/mL = group A, 370 mgI/mL = group B) during follow-up periods. The bolus-tracking program was used to automatically start the arterial phase scan. The attenuation values for the abdominal aorta, the hepatic parenchyma, and portal veins were measured.
RESULTS: Attenuation values of the aorta and hepatic artery in group B were significantly higher than those in group A (p<0.001). Attenuation values of the splenic vein (SV) in group A were higher than those in group B (p=0.045). The relative hepatic enhancement (RHE) values during the portal phase in group B were significantly higher than those in group A (p=0.014).
CONCLUSION: Administration of a higher iodine concentration in the contrast materials is advantageous for the detection of both hyper- and hypo-vascular hepatocellular carcinomas (HCCs).